Deciphering the dual nature of the Fibrosis-4 index in predicting hepatocellular carcinoma risk among hepatitis B patients undergoing nucleos(t)ide analog therapy

Hepatol Res. 2024 Feb;54(2):120-121. doi: 10.1111/hepr.13997. Epub 2024 Jan 20.

Authors

Jun Arai¹, Kiyoaki Ito¹

Affiliation

¹ Department of Gastroenterology, Aichi Medical University School of Medicine, Nagakute, Japan.

PMID: 38126190
DOI: 10.1111/hepr.13997

No abstract available

Publication types

Editorial

Grants and funding